Press Releases

Roswell Park has again been named to Becker’s Hospital Review’s 100 Hospitals and Health Systems with Great Oncology Programs, an annual list of centers that are national leaders in patient care, cancer outcomes and research. Roswell Park is one of only six New York State centers to be included, and the only one in Western and Upstate New York.

The Roswell Park Alliance Foundation has received the coveted ranking of 4 out of 4 stars from Charity Navigator, America’s largest independent charity evaluator, for its fourth consecutive year.

Roderich Schwarz, MD, PhD, has been appointed as the new Co-Director of the Liver and Pancreas Tumor Center at Roswell Park Comprehensive Cancer Center. He will also serve as a Professor of Oncology in the Department of Surgical Oncology.

Kunle Odunsi, MD, PhD, Deputy Director of Roswell Park Comprehensive Cancer Center, has been elected to the National Academy of Medicine — a distinguished lifetime designation that is considered one of the highest honors in health and medicine. The election of new members recognized for their outstanding professional achievements and commitment to service was announced today at the Academy’s annual meeting in Washington, D.C.

A new derivative of a compound found in the bark of a rare Chinese tree has powerful anticancer properties and a low toxicity profile, according to researchers at Roswell Park Comprehensive Cancer Center. Results of their study of the effects of the compound F118 in pancreatic cancer were published today in the Journal of Experimental & Clinical Cancer Research.

Initial results from the first North American clinical trial of CIMAvax-EGF show that this Cuban-developed immunotherapy is safe, well tolerated and worthy of further study. Principal Investigator Grace Dy, MD, of Roswell Park Comprehensive Cancer Center shared the findings yesterday at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada.

Governor Andrew M. Cuomo today announced Buffalo-based Roswell Park Comprehensive Cancer Center has formed Innovative Immunotherapy Alliance S.A., the first-ever biotech venture between the U.S. and Cuba. The announcement marks a significant milestone of progress following Governor Cuomo’s landmark trade mission to Cuba in April 2015, where he facilitated this historic partnership between Roswell Park and the Center for Molecular Immunology. This historic step will advance the research and development of new cancer medicines that may prolong and enhance survival for thousands of U.S. patients.

Through a grant award provided by the Cancer MoonshotSM, Roswell Park Comprehensive Cancer Center will support and advance some of the nation’s most ambitious cancer research projects.